INTRAVENOUS INJECTION OF NON-ENJOYABLE NEUROTOXICITY PLASMINOGEN ACTIVATORS FOR TREATMENT OF A IMPACT

摘要

The invention relates to the use of non-neurotoxic plasminogen activation factors, for example, from Desmodus rotundus (DSPA), or genetically modified plasminogen activation factors, in particular, of human origin, for the production of a pharmaceutical injection for therapeutic treatment of stroke in humans.